Background/Purpose: The prevalence of chlamydial infection is high among females treated in the preceding several months. CDC recommends retesting all females approximately 3 months after treatment for chlamydia, or whenever they next seek medical care within the following 3–12 months, regardless of whether the patient believes that her sex partners were treated.

Objectives of Symposium: Review local/regional approaches to measuring chlamydia retesting rates utilizing various data sources, and discuss strategies designed to increase retesting rates.

Implications for Programs, Policy, and/or Research: Increasing chlamydia retesting rates might lead to earlier identification and treatment of infection/reinfection among at-risk females, thereby reducing the risk for pelvic inflammatory disease and other complications.